New England Biolabs Inc. Sustainability Profile
New England Biolabs Inc. (NEB), headquartered in the United States, is a leading player in the biotechnology industry, specialising in the production of reagents for DNA research. Founded in 1974, NEB has established itself as a pioneer in molecular biology, with significant milestones including the development of innovative enzymes and reagents that have transformed genetic research. With a strong presence in major operational regions worldwide, NEB offers a diverse range of core products, including restriction enzymes, DNA polymerases, and cloning kits, all renowned for their quality and reliability. The company’s commitment to scientific advancement and customer support has solidified its market position, making it a trusted partner for researchers globally. NEB continues to drive innovation, contributing to breakthroughs in genomics and molecular biology.
DitchCarbon Score
How does New England Biolabs Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
New England Biolabs Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
New England Biolabs Inc.'s reported carbon emissions
New England Biolabs Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of publicly available information suggests that New England Biolabs may not have established formal commitments to reduce carbon emissions or may not disclose such data at this time. In the context of the biotechnology industry, many companies are increasingly focusing on sustainability and climate action, often setting science-based targets to align with global climate goals. However, without specific data or commitments from New England Biolabs, it is unclear how they are addressing climate change or carbon emissions within their operations.
How Carbon Intensive is New England Biolabs Inc.'s Industry?
How Carbon Intensive is New England Biolabs Inc.'s Location?
New England Biolabs Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
New England Biolabs Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
